4Filing Date: Sep 23, 2026

Hims & Hers Health

Statement of Changes in Beneficial Ownership

View SEC Filing
ACC: 0001907056-26-000026
Total Value$947.0K
Trades4
Insiders1

Transaction Details

Okupe Oluyemi
Chief Financial Officer·Direct
Exercise · Acquire
Class A Common Stock
Shares+14.00K
Price$5.01
Total Value$70.1K
Shares Owned After265.80K
Transaction DateSep 22, 2026
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Okupe Oluyemi
Chief Financial Officer·Direct
Sell · Dispose
Class A Common Stock
Shares-29.28K
Price$29.95
Total Value$876.8K
Shares Owned After236.53K
Transaction DateSep 22, 2026
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person.

Okupe Oluyemi
Chief Financial Officer·Direct
Exercise · Dispose
Stock Option (right to buy)Derivative
Shares-14.00K
Price$0.00
Total Value$0
Shares Owned After66.87K
Transaction DateSep 22, 2026
Exercise Price$5.01
ExpiresFeb 23, 2032
10b5-1
Footnotes ▸

The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. | This stock option award is fully vested.

Okupe Oluyemi
Chief Financial Officer·Indirect · Held by Oluyemi Okupe Separate Property Trust dtd 9-1-2021
Class A Common Stock
Shares0
Price-
Total Value$0
Shares Owned After7.85K
10b5-1Holding Only

Post-Transaction Holdings

Okupe Oluyemi · Chief Financial Officer
SecuritySharesChange
Class A Common Stock273.66K-15.28K (-5.29%)
Stock Option (right to buy)66.87K-14.00K (-17.31%)
auto_awesome

Deep Analysis

Hims & Hers CFO Oluyemi Okupe exercised 14,000 options at $5.01 and sold 29,277 shares at $29.95 for $876,846 — a net reduction of 15,277 shares — all under a pre-set Rule 10b5-1 plan.

lock
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-09-22 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: Hims & Hers Health, Inc. (HIMS) CIK: 0001773751 --- Reporting Owner --- Name: Okupe Oluyemi CIK: 0001907056 Role: Officer (Chief Financial Officer) --- Non-Derivative Transactions --- [Transaction #1] Security: Class A Common Stock Date: 2026-09-22 | Code: M (Exercise of derivative) Shares: +14,000 | Price: $5.01 Total Value: $70,140.00 Shares Owned After: 265,804 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. [Transaction #2] Security: Class A Common Stock Date: 2026-09-22 | Code: S (Open market sale) Shares: -29,277 | Price: $29.95 Total Value: $876,846.15 Shares Owned After: 236,527 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (right to buy) Date: 2026-09-22 | Code: M (Exercise of derivative) Shares: -14,000 | Price: $0.00 Exercise Price: $5.01 Exercisable: N/A | Expires: 2032-02-23 Shares Owned After: 66,872 | Ownership: D (Direct) Footnotes: [F1] The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. [F2] This stock option award is fully vested. --- Holdings --- [Holding #1] Security: Class A Common Stock Ownership: I (Indirect) --- Footnotes (Complete Index) --- F1: The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on May 20, 2026 by the Reporting Person. F2: This stock option award is fully vested. --- Signature --- /s/ /s/ Kimberly Mather, Attorney-in-Fact for Oluyemi Okupe (2026-09-23)

keid analysis is for reference only and does not constitute investment advice.